Skip to Content

A Randomized Phase 3 Interim Response Adapted Trial Comparing Standard Therapy with Immuno-oncology Therapy for Children and Adults with Newly Diagnosed Stage I and II Classic Hodgkin Lymphoma

Phase III Clinical Trial

Indication: Hodgkin Lymphoma
Trial Number: �05675410
Trial Status: OPEN

Participating Locations